NA

Nadim Ahmed

President and CEO

Cullinan Oncology

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Cullinan Oncology
Industry
research
Employees
130.0
Seniority
C suite
Annual Revenue
18943000.0

Technologies

Amazon SES Outlook ServiceNow Microsoft Office 365 Google Cloud Hosting Barracuda Networks

Keywords

oncology & autoimmune diseases biotechnology: biological products (no diagnostic substances) health care biotechnology research targeted therapeutics modality-agnostic oncology innovation patient benefit immunology research translational medicine clinical trials drug discovery biologics development cancer treatments autoimmune disease therapies pipeline of programs collaborative research strategic partnerships biotech company transformative therapeutics scientific collaborations clinical-stage assets health equity personalized medicine immuno-oncology therapeutic solutions dynamic leadership diversified portfolio capital financing expertise in drug development clinical research market access strategies regulatory affairs healthcare ecosystem cancer research biotechnology industry therapeutic modalities disease management cancer therapies innovative medicines patient-centric solutions production & supply chain biopharmaceuticals clinical data research & development pharmaceutical innovation healthcare collaboration biomedical research methodologies drug commercialization monoclonal antibodies first-in-class therapies new treatment options fda approval processes biotech leadership health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans